Prelude Therapeutics (PRLD) Prepaid Assets (2019 - 2026)
Prelude Therapeutics (PRLD) reported Prepaid Assets of $3.0 million for Q1 2026, down 8.71% on a YoY basis from $3.3 million in Q1 2025, and up 22.64% sequentially from $2.5 million in Q4 2025.
Prelude Therapeutics (PRLD) Prepaid Assets (2019 - 2026) Analysis & Trends
Prelude Therapeutics (PRLD) has 8 years of Prepaid Assets data on file, last reported at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 8.71% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 8.71% YoY), and the FY2025 full-year result was $2.5 million, up 8.64% from the prior year.
- Prepaid Assets improved to $3.0 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.2 million in Q2 2023 to a low of $2.3 million in Q4 2024.
- A 5-year average of $3.2 million and a median of $3.0 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 125.14% in 2023 and sank 45.03% in 2024, its largest moves.
- Tracing PRLD's Prepaid Assets over 5 years: stood at $2.7 million in 2022, then rose by 0.08% to $2.7 million in 2023, then slipped by 14.05% to $2.3 million in 2024, then climbed by 8.64% to $2.5 million in 2025, then increased by 22.64% to $3.0 million in 2026.
- Business Quant data shows PRLD's Prepaid Assets at $3.0 million in Q1 2026, $2.5 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 2.48 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 3.66 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 2.65 Mn |
| Sep 30, 2023 | 4.41 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.32 Mn |
| Mar 31, 2022 | 3.78 Mn |
| Dec 31, 2021 | 3.88 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 1.46 Mn |